Create Alert
Watchlist

Jenburkt Pharmaceuticals

₹1,254.80
+17.60 (1.42%) 1D
BSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
1,223.05
Prev. Close
1,237.20
Volume
741
Total traded value
0.09 Cr
Upper Circuit
1,484.60
Lower Circuit
989.80

Fundamentals

Market Cap₹546Cr
ROE18.04%
P/E Ratio(TTM)16.55
EPS(TTM)74.77
P/B Ratio2.99
Dividend Yield1.45%
Industry P/E40.24
Book Value414.39
Debt to Equity0.01
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Jenburkt Pharma

Jenburkt is a pharmaceutical company with 40 years of experience, rooted in the timeless Indian values of ethics, humility, and service to others. Its vision is to build trust in life sciences by delivering specialty, high-quality pharmaceutical formulations and healthcare products that bring positive change to families globally. The company's mission is to serve its patients and through them, contribute to God, Humanity, and the Nation, finding gratification in bringing smiles to patients' faces. It drives leadership in primary care by developing innovative therapies, building on its legacy as a pioneer in pain management to meet India's demand for effective relief. The company's portfolio combines world-first innovations with pioneering introductions to the Indian market, consistently focused on delivering solutions that transform lives. For the fiscal year 2024-25, the company recorded a profit before tax of ₹4,393.28 lacs, marking a significant rise of 24.89% year-on-year.;
Parent OrganisationJenburkt Pharmaceuticals Limited
Managing DirectorAshish U. Bhuta
BSE Symbol524731

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Retail And Others
53.22%
Promoters
46.66%
Other Domestic Institutions
0.12%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Torrent Pharmaceuticals
NA
(0.00%)
58.80
Ajanta Pharma
NA
(0.00%)
32.25
Gland Pharma
NA
(0.00%)
37.87
Eris Lifesciences
NA
(0.00%)
50.71